1998
DOI: 10.1016/s0361-9230(97)00449-8
|View full text |Cite
|
Sign up to set email alerts
|

Targeting the subthalamic nucleus in the treatment of Parkinson’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
22
0

Year Published

2001
2001
2019
2019

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(24 citation statements)
references
References 59 publications
2
22
0
Order By: Relevance
“…The STN has been observed to be overactive in animal models of PD (Bergman et al, 1994;Hassani et al, 1996;Nakao et al, 1998). However, Henderson and Dunnett (1998) have questioned the prediction of this model of STN hyperactivity as a result of Parkinsonianinduced GPe disinhibition. They suggest that the reception by the STN of excitatory inputs from the cortex and center medianparafascicular complex of the thalamus and inhibitory inputs from the SN and tegmentum make it possible that PD involves hyperactivity of the STN because of excessive excitatory cortical and parafascicular thalamic input and decreased inhibitory nigral and tegmental input to the STN.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The STN has been observed to be overactive in animal models of PD (Bergman et al, 1994;Hassani et al, 1996;Nakao et al, 1998). However, Henderson and Dunnett (1998) have questioned the prediction of this model of STN hyperactivity as a result of Parkinsonianinduced GPe disinhibition. They suggest that the reception by the STN of excitatory inputs from the cortex and center medianparafascicular complex of the thalamus and inhibitory inputs from the SN and tegmentum make it possible that PD involves hyperactivity of the STN because of excessive excitatory cortical and parafascicular thalamic input and decreased inhibitory nigral and tegmental input to the STN.…”
Section: Discussionmentioning
confidence: 99%
“…The STN is being increasingly recognized as having a central role in basal ganglia physiology and PD pathophysiology (Henderson and Dunnett, 1998). Decreased dopamine levels in the ST are thought to alter striatal function, including reduced activity of GABA/substance P/dynorphin medium spiny neurons and reduced inhibition of GABA/enkephalin medium spiny neurons, which render the globus pallidus pars externus (GPe) hypoactive by provoking excessive inhibition (Rodriguez et al, 1998).…”
mentioning
confidence: 99%
“…Thalamic 5-[ 125 I]-A-85380 binding in PD also tended to be lower than in DLB, with significance reached in the STH nucleus. Dopamine deficiency in PD causes the disinhibition and overactivity of the STH nucleus and its projections to the internal GP, which in turn overinhibits thalamocortical projections which is thought to be responsible for the appearance of symptoms such as akinesia, rigidity, and perhaps tremor (Henderson and Dunnett, 1998) , and PD and in the substantia nigra in DLB and PD differentiates these groups from VaD as well as controls. This could be valuable in differentiating VaD from primary degenerative dementia.…”
Section: Disease Comparisonsmentioning
confidence: 99%
“…The goal of DBS of the subthalamic nucleus is to inactivate inhibitory function thereby allowing the remaining pathways to function, despite reduced activation from the degenerated substantia nigra (McIntyre, Savasta, Kerkerian-Le Goff, & Vitek, 2004; Trost et al, 2006). Despite great success in reducing tremor, rigidity, and hypokinesia (Henderson & Dunnett, 1998), there may be a disconnect between positive outcomes for speech and nonspeech movements (see Kent et al, 2001). Clinical anecdotes, preliminary evidence, and patient reports suggest speech may not improve or may even worsen post-DBS in some people.…”
Section: Introductionmentioning
confidence: 99%